Bernard Coulie, President and CEO: Pliant Therapeutics PLRX Sell · Filed 24/07/12

Trade details

Type: Insider sale
Amount: $447,487.6
Shares · price: 38,710 sh · $11.56 a share
Held after: 482,936 sh
Stock: Pliant Therapeutics PLRX
Person: Bernard CouliePresident and CEO
Trade date: 24/07/10
Filed: 24/07/12
Days to filing: 2 days

Sold 7.4% of holdings

Share of holding sold: 7.4%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/10~24/08/09

Bernard Coulie's recent trades

Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
89,375 sh
$114.4K
Filed 01/22
Traded 01/20
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$587.1K
52,419 sh
$587.1K
Filed 25/01/22
Traded 25/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$443.2K
25,721 sh
$443.2K
Filed 24/01/19
Traded 24/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$1.3M
70,150 sh
$1.3M
Filed 23/07/19
Traded 23/07/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$937.2K
35,339 sh
$937.2K
Filed 23/04/03
Traded 23/03/30

Bernard Coulie, CEO — sold $447.5K of Pliant Therapeutics PLRX · 7.4% of holdings · 10b5-1 plan | Whalegun